Kura Oncology, Inc.KURANASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank93
3Y CAGR+52.1%
5Y CAGR+36.8%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
+52.1%/yr
vs -8.0%/yr prior
5Y CAGR
+36.8%/yr
Recent acceleration
Acceleration
+60.1pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
4.8x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.12+192.8%
20240.04-7.3%
20230.04+29.7%
20220.03+145.9%
20210.01-44.6%
20200.02-30.8%
20190.04-23.9%
20180.05-47.6%
20170.09-31.0%
20160.13-